FDA Inspection
Carter BloodCareCarter BloodCare – FDA Inspection, Feb 14, 2020
Record Details
This FDA Inspection record concerns Carter BloodCare, with an inspection on February 14, 2020, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Carter BloodCare
- Inspection Date
- February 14, 2020
- Product Type
- Biologics
View Company Profile
ID · 5af8a736-088d-41ab-bd30-828bb9121553
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1118763
- FDA center
- Biologics
- Project area
- Blood and Blood Products
Other FDA inspections of Carter BloodCare
6| Date | Classification | Office | Project area |
|---|---|---|---|
| December 17, 2024 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| October 5, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| October 6, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| March 26, 2014 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| March 26, 2012 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Carter BloodCare
- FDA Inspection 1257153 - 2024-12-17
- FDA Inspection 1028502 - 2017-10-05
- FDA Inspection 945067 - 2015-10-06
- FDA Inspection 871498 - 2014-03-26
- FDA Inspection 774031 - 2012-03-26
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.